Illumina, Inc. vs Palo Alto Networks Inc — how do they compare? Illumina, Inc. trades at $193.06 (market cap $29.12B), while Palo Alto Networks Inc trades at $381.02 (market cap $312.80B). The key difference: Palo Alto Networks Inc is far larger — about 10.7× Illumina, Inc.'s market cap. Which is the better fit depends on your goals.
| ILMN | PANW | |
|---|---|---|
Market Cap | $29.12B | $312.80B |
Sector | Health | Technology |
52-Week High | $205.10 | $385.04 |
52-Week Low | $91.00 | $141.67 |
Enterprise Value | $30.48B | $311.76B |
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →